Evidence map›Paper›PMID 31132764›Full record

ReviewOphthalmic research2019

Update on Screening for Sight-Threatening Diabetic Retinopathy.

Peter H Scanlon

Open access · hybridAbstract readReview
In one paragraph

Review in Ophthalmic research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Diabetic retinal disease.Nature reviews. Disease primers · 2025
    Review
  3. Diabetic retinopathy-recommendations for screening and treatment.Wiener medizinische Wochenschrift (1946) · 2025
    Review
  4. Comparing code-free and bespoke deep learning approaches in ophthalmology.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Comparison of 2-Field and 5-Field Mydriatic Handheld Retinal Imaging in a Community-Based Diabetic Retinopathy Screening Program.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2023
    Article
  12. Article
  13. Article
  14. The Narrative Medicine Approach in the Treatment of Diabetic Macular Edema: An Italian Experience.International journal of environmental research and public health · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Imaging the eye and its relevance to diabetes care.Journal of diabetes investigation · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Peter H ScanlonClinical Director English NHS Diabetic Eye Screening Programme, Cheltenham, United Kingdom, p.scanlon@nhs.net.
University of Gloucestershire · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this article was to describe recent advances in the use of new technology in diabetic retinopathy screening by looking at studies that assessed the effectiveness and cost-effectiveness of these technologies.

methodsThe author conducts an ongoing search for articles relating to screening or management of diabetic retinopathy utilising Zetoc with keywords and contents page lists from relevant journals.

resultsThe areas discussed in this article are reference standards, alternatives to digital photography, area of retina covered by the screening method, size of the device and hand-held cameras, mydriasis versus non-mydriasis or a combination, measurement of distance visual acuity, grading of images, use of automated grading analysis and cost-effectiveness of the new technologies.

conclusionsThere have been many recent advances in technology that may be adopted in the future by screening programmes for sight-threatening diabetic retinopathy but each device will need to demonstrate effectiveness and cost-effectiveness before more widespread adoption.

Indexed as

Diabetic RetinopathyGlobal HealthHumansIncidenceMass ScreeningPhotographyRetinaVisual AcuityImagingRetinal screeningRetinopathySight-threatening diabetic retinopathyVisual loss

Identifiers

PMID31132764
PMCPMC6943807
OpenAlexW2947363957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.